Regenerative Medicine and Tissue Engineering 2013
DOI: 10.5772/55580
|View full text |Cite
|
Sign up to set email alerts
|

Delivery Systems and Role of Growth Factors for Alveolar Bone Regeneration in Dentistry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(18 citation statements)
references
References 78 publications
0
18
0
Order By: Relevance
“…With regard to the incorporation of bioactive molecules for localized and controlled delivery [18,19], in one study [115] VEGF, a potent angiogenic factor, was successfully encapsulated within a PEEK/biphasic bioceramic composite scaffold and found to facilitate the vascular remodeling in vivo.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…With regard to the incorporation of bioactive molecules for localized and controlled delivery [18,19], in one study [115] VEGF, a potent angiogenic factor, was successfully encapsulated within a PEEK/biphasic bioceramic composite scaffold and found to facilitate the vascular remodeling in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Another strategy to produce scaffolds with tailored mechanical properties and resorbability, based on application needs, consists of the development of composite materials, containing bioceramics and polymers in different ratios [16,17]. To improve the performances of bioceramic scaffolds, the incorporation of growth factors stimulating osteogenesis and angiogenesis has been described [18,19]. Moreover, bone scaffolds could act as stem cell carriers for accelerating bone repair [20].…”
Section: Introductionmentioning
confidence: 99%
“…14 Consequently, a recombinant isoform of PDGF (rhPDGF-BB) was synthesized and found to be potent in exerting chemotactic and osteoproliferative actions through cell surface tyrosine kinase receptors. 22 While several studies have reported beneficial effects on bone healing when combining rhP-DGF-BB with osteoconductive scaffolds, 10,12,21,[30][31][32][33] the present study evaluated the adjunct role of rhPDGF-BB along with equine bone and beta-TCP for GBR of segmental defects (femoral CSSD), which has not been reported earlier. Although, BMPs and MSCs have been reported as adjuncts to GBR, they are associated with disadvantages, such as uncontrolled bone formation seen with BMPs and difficulty in cell culture and isolation of MSCs.…”
Section: Discussionmentioning
confidence: 95%
“…Healing bone tissue expresses BMP and PDGF for mesenchymal cell differentiation and proliferation, and the addition of these factors could potentially render osteoconductive graft materials as osteoinductive. 6,22 PDGF is released from the alpha-granules of platelets in response to injury and is chemically characterized as a dimer derived from PDGF-A/B polypeptide chains. 28,29 Interestingly, PRP which is considered to release PDGF through platelet lysis, availed no clinical benefit towards osseous healing and regeneration.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation